Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-05-18, Stock:ABBV, The news for the past five days is as follows:
2020-05-11: NEWS1: The Dow Slipped 109 Points Because Reopened Economies Aren’t Business as Usual.NEWS2: AbbVie Stock Is ‘Unsustainably Cheap’ After Allergan Acquisition.NEWS3: AbbVie Garners Two Favorable Analyst Reviews After Allergan Merger.NEWS4: The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance.NEWS5: Form 8.3 - AbbVie Inc..NEWS6: AbbVie Wraps Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?.NEWS7: Form 8.3 - ABBVIE INC.
2020-05-12: NEWS1: Wall Street Ends in the Red on Tuesday.NEWS2: The Dow Can’t Hang On — and REITs Are Getting Crushed.NEWS3: The Dow Is Hanging On — REITs Are Most Certainly Not.NEWS4: AbbVie Is a Buy as Allergan Deal Closes - A Look at the Charts.NEWS5: FORM 8.3 - ABBVIE INC - Amendment.NEWS6: AbbVie Stock Has 15% Upside With Merger Done, J.P. Morgan Analyst Says.NEWS7: Reata (RETA) Q1 Earnings Surpass Estimates, Revenues Miss.NEWS8: AbbVie Gets Favorable Analyst Reviews After Allergan Merger.NEWS9: AbbVie Inc. Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next.
2020-05-13: NEWS1: Dow Jones Slides 1,171 Points In 3 Days After Fed Chair Speech Sharpens Recession Fear.NEWS2: AbbVie's Potential Is 'Underappreciated,' Says Morgan Stanley Analyst.NEWS3: 2 Value Stocks That Will Make You Richer in May.NEWS4: 3 Stocks That Could Help You Send Your Kids to College.NEWS5: AbbVie Announces Final Results of Exchange Offers for Allergan Notes.NEWS6: Is AbbVie a Buy Now That the Allergan Deal Is Done?.
2020-05-14: NEWS1: AbbVie to Present at the UBS Virtual Healthcare Conference.NEWS2: Is Now a Good Time To Buy Neurocrine Biosciences?.
2020-05-15: NEWS1: Top Stock Reports for JPMorgan, AbbVie & Royal Dutch Shell.NEWS2: Pharma Stock Roundup: FDA Updates for LLY, AZN, MRK, BMY and SNY.NEWS3: AbbVie Data at EHA Annual Congress Highlight Depth and Breadth of Transformative Blood Cancer Portfolio.

Answer: Rise